Feature

Billions of dollars potentially at stake as Johnson & Johnson stands trial for alleged role in opioid epidemic

May 28, 2019
Opening arguments were slated to start Tuesday, May 28, in the second opioid lawsuit that the state of Oklahoma has brought against an opioid…
In the Journals

Golimumab efficacy maintained through 1 year in AS

May 28, 2019
Intravenous golimumab, administered in doses of 2 mg per kg, maintained its efficacy through 1 year in patients with ankylosing spondylitis, with no…
Meeting News

Checkpoint inhibitor management represents 'quintessential' interdisciplinary juncture

May 24, 2019
CLEVELAND — Interdisciplinary management of immune-related adverse events associated with checkpoint inhibitors, with collaboration between…
Q&A With Healio Rheumatology

Speaking the Language: Health care execs join United Rheumatology to advocate for independent practice

May 24, 2019
In the ever-changing landscape of the United States health care system, rheumatologists need a voice. They need a voice in managing the complex web…
Meeting News

Stem cells likely 'way of the future' in systemic sclerosis treatment

May 23, 2019
CLEVELAND — Autologous hematopoietic stem cell transplantation, which has recently emerged as a potentially effective option for select…
Meeting News

Medications under FDA review face significant scrutiny on their printed materials

May 23, 2019
WASHINGTON — The FDA’s Office of Prescription Drug Promotion uses many methods to assess the validity of a potential medication’s…

Regulation of data privacy may affect US advancement in AI

May 23, 2019
WASHINGTON — Federal regulations regarding data privacy and collection may lead to the United States falling behind countries like China in…
In the Journals

Orofacial dysfunctions reported in more than half of patients with early-course JIA

May 23, 2019
Orofacial symptoms are present in approximately 38% of patients with juvenile idiopathic arthritis, with orofacial dysfunctions prevalent in an…
Meeting News

CMS aims to increase drug pricing transparency through price disclosure legislation

May 22, 2019
WASHINGTON — In a presentation at the Rising Leaders Conference on Healthcare Policy, Kate Rawson discussed what to expect with the…
Meeting News

Patients with scleroderma require 'annual screening' for pulmonary arterial hypertension

May 22, 2019
CLEVELAND — Every patient with systemic sclerosis should be screened for pulmonary arterial hypertension every year, as early recognition…
Meeting News

Uncertain future ahead for FDA without full-time commissioner

May 22, 2019
WASHINGTON — Following nearly 2 years under the leadership of Commissioner Scott Gottlieb, MD, the FDA and its Acting Commissioner Norman E…
Editorial

What Can Healio Rheumatology Do For You?

Healio Rheumatology, May
Leonard H. Calabrese, DO
Only a few short years since our inaugural issue in March 2016, Healio Rheumatology is still a relatively new publication, but one that is…
Cover Story

Joint Ventures in Complicated Patients: Advent of Derm-rheum Clinics

Healio Rheumatology, May
Among health care professionals, discomfort can be the mother of invention, to coin a phrase. Rheumatologists have long voiced uncertainty about…
Meeting News

Aging HIV population face complicated rheumatologic care

May 22, 2019
CLEVELAND — As the national population of patients who are HIV-positive continues to age, rheumatologists will be increasingly called on to…
In the Journals

Abatacept has highest overall retention rate among seven biologics for RA

May 21, 2019
Among seven biologic treatments for rheumatoid arthritis, tocilizumab exhibited the lowest discontinuation rate due to lack of effectiveness, while…
Meeting News

IgG4 role overplayed in the inflammatory 'symphony' of IgG4-related disease

May 21, 2019
CLEVELAND — The IgG4 molecule has been overstated in the understanding of IgG4-related disease, and it may be more helpful to view this…
In the Journals

Glucocorticoid use tied to increased risk for infection in patients with RA after arthroplasty

May 20, 2019
Patients with rheumatoid arthritis who used glucocorticoids and underwent knee or hip arthroplasty were at an increased risk for adverse events…
In the Journals

Golimumab reduces PsA signs, symptoms through one year

May 20, 2019
Intravenous golimumab, in doses of 2 mg per kg, reduced the signs and symptoms of psoriatic arthritis through1 year, with improvements in…
Meeting NewsPerspective

Nintedanib slows loss of pulmonary function in systemic sclerosis-associated interstitial lung disease

May 20, 2019
DALLAS — Patients with interstitial lung disease associated with systemic sclerosis treated with the tyrosine kinase inhibitor nintedanib…
In the Journals

Increasing tocilizumab dose interval reduces chance of maintaining remission in RA

May 20, 2019
Increasing the dose interval of subcutaneous tocilizumab is associated with a lower chance of maintaining remission after 24 weeks, and is not linked…